Speaker illustration

Doctor Stanislav Pekarskiy

Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk (Russian Federation)

Member of:

EAPCI
Heart Failure Association

Sustained strong blood pressure lowering and preserved renal function during 3 year after anatomically optimized distal renal denervation according to the double blind randomized controlled study

Event: ESC Congress 2021 - The Digital Experience

Topic: Device Treatment and Intervention

Session: Hypertension e-posters

Thumbnail

Efficacy of radiofrequency RDN may be significantly improved if the procedure is guided by impedance drop during the treatment

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Device Treatment and Intervention

Session: Devices in Hypertension

Thumbnail

Electrophysiology-based assessment of the procedural success of radiofrequency renal denervation

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Device Treatment and Intervention

Session: Devices in Hypertension

Thumbnail

A safety of distal renal denervation in segmental braches of renal artery as assessed by optical coherence tomography

Event: ESC CONGRESS 2019

Topic: Device Treatment and Intervention

Session: Hypertension treatment: drugs and devices

Thumbnail

Distal renal denervation in segmental branches of renal artery versus conventional main trunk therapy: 12 months study in patients with resistant hypertension

Event: ESC CONGRESS 2017

Topic: Devices / interventions

Session: Innovations in hypertension management and devices

Thumbnail

Distal renal denervation performed mainly in segmental branches of renal artery versus conventional mode of the intervention: a randomized controlled trial in patients with resistant hypertension

Event: ESC CONGRESS 2016

Topic: Renal denervation

Session: Renal denervation, aortic and carotid disease

Thumbnail

This platform is supported by

logo Novo Nordisk